← All indications
Gingivitis
Inflammation of gum tissue (GINGIVA) without loss of connective tissue.
Subtype terms (2)
More specific conditions that are subtypes of Gingivitis in the MeSH hierarchy.
- Gingival Pocket
2 drugs (1 approved, 1 experimental)
- Gingivitis, Necrotizing Ulcerative
Drugs by status
Approved for this indication (10)
Phase 4 trials (19)
- metronidazole
- stearyl trihydroxyethyl propylenediamine dihydrofluoride
- cetylpyridinium chloride
- essential oils
- ethanol
- Eucalyptol
- cow milk
- autologous microbiome
- acacia
- lactobacillus brevis
- oligomeric proanthocyanidins
- ethyl lauroyl arginate
- copolymer
- sodium chloride
- triclosan
- water
- calcium phosphate
- stannous fluoride
- sodium fluoride
Phase 3 trials (9)
Phase 2 trials (16)
Phase 1 trials (7)
Other trials (32)
- sodium nitrate
- vitamin d3
- sucrose
- chitosan
- delmopinol hydrochloride
- ilex rotunda
- lotus leaf
- myrrha (commiphora myrrha)
- nicotine
- propylene glycol
- punica granatum
- lactoferrin
- sesame oil
- pelargonium
- collagen
- xylitol
- ocimum sanctum
- azithromycin
- fatty acid
- lactobacillus curvatus
- sodium bicarbonate
- licorice
- ubiquinone
- lactobacillus casei
- lactobacillus reuteri
- nitrate
- lactobacillus rhamnosus
- lettuce
- leupeptin
- zinc ascorbate
- +2 more
Organizations
Organization Involved with Phase 4 Indications (21)
- Gaba International AG
- GlaxoSmithKline
- Colgate Palmolive
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Loma Linda University
- Mahidol University
- Tatyasaheb Kore Dental College
- Universidad de Antioquia
- University of Milan
- University of Oslo
- University of Santiago de Compostela
- University of Seville
- University of Taubate
- Aga Khan University
- Procter and Gamble
- University of Sassari
- University of Texas at Houston
- University of Gothenburg
- Technical University of Dresden
- Kiss Industries LLC
Organization Involved with Phase 3 Indications (12)
- CD Pharma India Pvt. Ltd.
- Lion Corporation
- Schülke & Mayr GmbH
- Federal University of Minas Gerais
- Nihon University
- Osaka University
- Sri Hasanamba Dental College and Hospital
- Tohoku University
- Universidade Federal de Minas Gerais
- Government Dental College and Hospital, Vijayawada, Andhra Pradesh
- Taibah University
- University of Applied Sciences Würzburg-Schweinfurt
Organization Involved with Phase 2 Indications (23)
- Biomedical Development Corporation
- National Center for Research Resources (NCRR)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Dental and Craniofacial Research (NIDCR)
- United States Army
- Harvard University
- Indiana University
- Specialized Arab Hospital
- The Forsyth Institute
- Universidade Federal do Rio Grande do Norte
- University of Kentucky
- University of Toronto
- University of Chile
- University of Baghdad
- University of Tabriz
- Federal University of Paraiba
- Hebrew University
- University of Texas, San Antonio
- University of Western Ontario
- Ontario Centres of Excellence
- Integra LifeSciences Corporation
- The University of Texas, Dallas
- Amyndas Pharmaceuticals S.A.
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (22)
- GenMont Biotech Incorporation
- University of Pennsylvania
- Baskent University
- Boston University
- Julius-Maximilians University
- Kaohsiung Medical University
- Universidade Estadual da Paraiba
- University of Lisbon
- University of Tehran
- Kuwait University
- St. Louis University
- University of Copenhagen
- Sun Yat-Sen University
- University of Alabama
- German Naval Medical Institute
- Triumph Pharmaceuticals
- West China College of Stomatology
- Instituto Piaget
- Government College of Dentistry, Indore
- Glo Science, Inc.
- MAHSA University
- King Abdul-Aziz University